A detailed history of Y Intercept (Hong Kong) LTD transactions in Icon PLC stock. As of the latest transaction made, Y Intercept (Hong Kong) LTD holds 4,162 shares of ICLR stock, worth $789,281. This represents 0.08% of its overall portfolio holdings.

Number of Shares
4,162
Previous 19,017 78.11%
Holding current value
$789,281
Previous $5.96 Million 79.94%
% of portfolio
0.08%
Previous 0.34%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

SELL
$280.48 - $346.2 $4.17 Million - $5.14 Million
-14,855 Reduced 78.11%
4,162 $1.2 Million
Q2 2024

Aug 14, 2024

BUY
$288.23 - $331.73 $5.48 Million - $6.31 Million
19,017 New
19,017 $5.96 Million
Q3 2023

Nov 14, 2023

BUY
$236.44 - $265.62 $730,599 - $820,765
3,090 New
3,090 $760,000
Q1 2023

May 09, 2023

BUY
$193.59 - $245.33 $906,388 - $1.15 Million
4,682 Added 233.63%
6,686 $1.43 Million
Q4 2022

Feb 14, 2023

SELL
$173.9 - $224.8 $509,527 - $658,664
-2,930 Reduced 59.38%
2,004 $389,000
Q3 2022

Feb 14, 2023

BUY
$183.25 - $247.5 $692,501 - $935,302
3,779 Added 327.19%
4,934 $906,000
Q2 2022

Aug 08, 2022

BUY
$197.3 - $261.32 $227,881 - $301,824
1,155 New
1,155 $250,000
Q1 2022

May 16, 2022

SELL
$216.09 - $296.03 $393,283 - $538,774
-1,820 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$258.11 - $309.7 $47,492 - $56,984
184 Added 11.25%
1,820 $564,000
Q3 2021

Nov 15, 2021

SELL
$208.53 - $283.04 $741,949 - $1.01 Million
-3,558 Reduced 68.5%
1,636 $429,000
Q2 2021

Aug 26, 2021

BUY
$194.07 - $232.2 $1.01 Million - $1.21 Million
5,194 New
5,194 $1.07 Million
Q2 2021

Aug 12, 2021

BUY
$194.07 - $232.2 $0 - $0
0 New
0 $1.07 Million

Others Institutions Holding ICLR

About ICON PLC


  • Ticker ICLR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 81,526,600
  • Market Cap $15.5B
  • Description
  • ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development proces...
More about ICLR
Track This Portfolio

Track Y Intercept (Hong Kong) LTD Portfolio

Follow Y Intercept (Hong Kong) LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Y Intercept (Hong Kong) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Y Intercept (Hong Kong) LTD with notifications on news.